Travere Therapeutics, Inc.

TVTX·NASDAQ·$44.29Share Price as of 11/2·$4BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/04/26 10-QQ1 ended 03/31/2605/04/26 10-KFY 202502/19/26 10-QQ3 ended 09/30/2510/30/25 10-QQ2 ended 06/30/2508/06/25

Disclosures

8-KCurrent report09/21/26 8-KCurrent report08/04/26 8-KCurrent report07/09/26 8-KCurrent report06/16/26 8-KCurrent report06/02/26

Prospectuses and Registrations

S-8Registration of securities for employees06/17/26 424B5Prospectus supplement05/07/26 FWPFree writing prospectus05/07/26 424B5Prospectus supplement05/05/26 S-8Registration of securities for employees06/17/25

Proxies

DEF 14ADefinitive proxy04/06/26 DEFA14AAdditional proxy materials04/06/26 DEF 14ADefinitive proxy04/01/25 DEFA14AAdditional proxy materials04/01/25 DEF 14ADefinitive proxy03/27/24

Ownership

Form 4Insider transaction10/19/26 144Proposed sale of securities10/15/26 144Proposed sale of securities09/17/26 144Proposed sale of securities09/17/26 Form 4Insider transaction09/17/26

Other

305B2305B205/07/26 ARSAnnual report to shareholders04/06/26 ARSAnnual report to shareholders04/01/25 ARSAnnual report to shareholders03/27/24 305B2305B203/09/22